Plus Therapeutics Faces Delisting Concerns
Ticker: PSTV · Form: 8-K · Filed: May 19, 2025 · CIK: 1095981
| Field | Detail |
|---|---|
| Company | Plus Therapeutics, Inc. (PSTV) |
| Form Type | 8-K |
| Filed Date | May 19, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
PLUS is on the chopping block for delisting - stock might be toast.
AI Summary
Plus Therapeutics, Inc. filed an 8-K on May 19, 2025, reporting a notice of delisting or failure to meet continued listing standards as of May 16, 2025. The company, formerly known as Cytori Therapeutics, Inc. and Macropore Inc., is incorporated in Delaware and headquartered in Houston, Texas.
Why It Matters
This filing indicates potential issues with the company's ability to remain listed on an exchange, which could significantly impact its stock liquidity and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's public trading status, creating significant uncertainty and risk for investors.
Key Players & Entities
- PLUS THERAPEUTICS, INC. (company) — Registrant
- CYTORI THERAPEUTICS, INC. (company) — Former company name
- MACROPORE INC (company) — Former company name
- May 16, 2025 (date) — Date of earliest event reported
- May 19, 2025 (date) — Date of report
FAQ
What specific listing rule or standard has Plus Therapeutics, Inc. failed to meet?
The filing does not specify the exact listing rule or standard that Plus Therapeutics, Inc. has failed to meet, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on May 16, 2025.
What is the principal executive office address for Plus Therapeutics, Inc.?
The principal executive offices of Plus Therapeutics, Inc. are located at 2710 Reed Road, Suite 160, Houston, Texas 77051.
What are the former names of Plus Therapeutics, Inc. mentioned in the filing?
The filing mentions that Plus Therapeutics, Inc. was formerly known as Cytori Therapeutics, Inc. and Macropore Inc.
What is the Commission File Number for Plus Therapeutics, Inc.?
The Commission File Number for Plus Therapeutics, Inc. is 001-34375.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 19, 2025 regarding PLUS THERAPEUTICS, INC. (PSTV).